Sign up to save your podcasts
Or
Share Pre-Session Views
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pre-Session Views
In today's views
- Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
- MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
- CICH | 9M25 resilience underscores our EGP13/share fair value
- TWSA | Preliminary indicators show promising growth in factoring
View all episodes
By Al Ahly PharosIn today's views
- Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
- MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
- CICH | 9M25 resilience underscores our EGP13/share fair value
- TWSA | Preliminary indicators show promising growth in factoring
More shows like Al Ahly Pharos
View all
We Study Billionaires - The Investor’s Podcast Network
3,378 Listeners
FT News Briefing
668 Listeners
The World in Brief from The Economist
1,075 Listeners
G.Talks - The Podcast for Dreamers
6 Listeners
EnterpriseAM | Egypt
4 Listeners